{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:44:35Z","timestamp":1766400275281,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ctro.2024.100827","type":"journal-article","created":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T22:01:31Z","timestamp":1722204091000},"page":"100827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5122-2242","authenticated-orcid":false,"given":"Chunyu","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-2524","authenticated-orcid":false,"given":"Kusheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2024.100827_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 2","key":"10.1016\/j.ctro.2024.100827_b0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ctro.2024.100827_b0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2007.09.022","article-title":"Prospective randomized comparison of monthly flfluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer","volume":"108","author":"Kim","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ctro.2024.100827_b0020","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1200\/JCO.2007.11.9610","article-title":"Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology","volume":"25","author":"Hamstra","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2024.100827_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1148\/radiol.11101821","article-title":"Diffusion-weighted MR imaging in the head and neck","volume":"263","author":"Thoeny","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.ctro.2024.100827_b0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1593\/neo.81328","article-title":"Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations","volume":"11","author":"Padhani","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.ctro.2024.100827_b0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.oraloncology.2013.05.005","article-title":"Updates on MR imaging and 18F-FDG PET\/CT imaging in nasopharyngeal carcinoma","volume":"50","author":"Lai","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctro.2024.100827_b0040","doi-asserted-by":"crossref","first-page":"e4320","DOI":"10.1097\/MD.0000000000004320","article-title":"Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma","volume":"95","author":"Hou","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.ctro.2024.100827_b0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.mri.2005.11.005","article-title":"Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer","volume":"24","author":"Pickles","year":"2006","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.ctro.2024.100827_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13014-020-01738-6","article-title":"Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer","volume":"16","author":"Zhao","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100827_b0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/ijri.IJRI_441_18","article-title":"Role of apparent diffusion coefficient as a biomarker in the evaluation of cervical cancer","volume":"29","author":"Dashottar","year":"2019","journal-title":"Indian J Radiol Imaging"},{"key":"10.1016\/j.ctro.2024.100827_b0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mri.2020.06.014","article-title":"Prediction of early response to concurrent chemoradiotherapy in cervical cancer: value of multi-parameter MRI combined with clinical prognostic factors","volume":"72","author":"Zheng","year":"2020","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.ctro.2024.100827_b0065","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.21873\/anticanres.14873","article-title":"Pre-treatment apparent diffusion coefficient does not predict therapy response to radiochemotherapy in cervical cancer: a systematic review and meta-analysis","volume":"41","author":"Meyer","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ctro.2024.100827_b0070","doi-asserted-by":"crossref","first-page":"e005","DOI":"10.1136\/jitc-2022-005092","article-title":"Imaging endpoints for clinical trial use: a RECIST perspective","volume":"10","author":"Liti\u00e8re","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ctro.2024.100827_b0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13014-015-0493-6","article-title":"Time-window of early detection of response to concurrent chemoradiation in cervical cancer by using diffusion-weighted MR imaging: a pilot study","volume":"10","author":"Liu","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100827_b0080","doi-asserted-by":"crossref","first-page":"e17943","DOI":"10.1097\/MD.0000000000017943","article-title":"Intravoxel incoherent motion diffusion-weighted imaging evaluated the response to concurrent chemoradiotherapy in patients with cervical cancer","volume":"98","author":"Bian","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.ctro.2024.100827_b0085","doi-asserted-by":"crossref","unstructured":"Fliedner FP, Engel TB, El-Ali HH, et al. Diffusion weighted magnetic resonance imaging (DW-MRI) as a non-invasive, tissue cellularity marker to monitor cancer treatment response. BMC Cancer 2020; 20:134.","DOI":"10.1186\/s12885-020-6617-x"},{"key":"10.1016\/j.ctro.2024.100827_b9000","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/nbm.3458","article-title":"Diffusion MRI in early cancer therapeutic response assessment","volume":"30","author":"Galb\u00e1n","year":"2017","journal-title":"NMR Biomed"},{"key":"10.1016\/j.ctro.2024.100827_b0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2015.10.006","article-title":"Role of conventional and diffusion weighted MRI in predicting treatment response after low dose radiation and chemotherapy in locally advanced carcinoma cervix","volume":"117","author":"Das","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100827_b0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mri.2013.12.007","article-title":"The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer","volume":"32","author":"Kuang","year":"2014","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.ctro.2024.100827_b0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12885-016-2116-5","article-title":"Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging","volume":"16","author":"Zhu","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2024.100827_b0110","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/0284185120943046","article-title":"Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET\/CT and MRI in locally advanced cervical cancer","volume":"62","author":"Min","year":"2021","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ctro.2024.100827_b0115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/ijgc-2018-000095","article-title":"A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer","volume":"29","author":"Huang","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ctro.2024.100827_b0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.21147\/j.issn.1000-9604.2019.02.13","article-title":"Nomograms based on HPV load for predicting survival in cervical squamous cell carcinoma: an observational study with a longterm follow-up","volume":"31","author":"Zuo","year":"2019","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.ctro.2024.100827_b0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13014-019-1355-4","article-title":"The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer","volume":"14","author":"Fu","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100827_b0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.anndiagpath.2015.06.008","article-title":"Microvessel density and ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?","volume":"19","author":"Singh","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.ctro.2024.100827_b0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.32604\/Oncologie.2021.015906","article-title":"Tug1 indicate unfavorable prognosis of gastric cancer for promoting proliferation, migration and multidrug resistance","volume":"23","author":"Liu","year":"2021","journal-title":"Oncologie"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T11:13:12Z","timestamp":1728126792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":27,"alternative-id":["S2405630824001046"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100827","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100827"}}